CompletedNot Applicable

A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia

Indonesia600 participantsStarted 2022-11-28

Plain-language summary

This study is a sero-survey study of infants aged 6 months to 71 months in Bandung City and West Bandung District. As initial data to find out how many children have been exposed to human enterovirus type 71 (HEV-71) which causes Hand, foot, and mouth disease (HFMD).

Who can participate

Age range6 Months – 71 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children aged 6 months to 71 months. * The participant's parent/guardian receives an explanation and receives a Letter of Consent after the explanation (informed consent) and provided a documented informed consent by parents/legally accepted representative (LAR) participants prior to the study procedures. * Domicile in Bandung and West Bandung District for at least 6 months. Exclusion Criteria: * Children with difficulty to withdraw the blood during blood collection * Children with severe illness who require further treatment

What they're measuring

Seroprevalence of EV71 antibodies

Timeframe: Immediately after sampling

Trial details

NCT IDNCT05637229

SponsorSinovac Biotech Co., Ltd

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2022-12-19

View on ClinicalTrials.gov More Hand, Foot and Mouth Disease trials